Healio: Sotagliflozin reduces CV risk in patients with LV hypertrophy without high BP Please provide your email address to receive an email when new articles are posted on . LV hypertrophy without high BP increased risk for CV events, CV death and HF hospitalization. The dual ...

Understanding the Context

Sotagliflozin reduces CV risk in patients with LV hypertrophy without high BP Healio: Intensive BP lowering reduces CV events in patients with hypertension, LV hypertrophy Please provide your email address to receive an email when new articles are posted on . In a cohort of patients with hypertension and left ventricular hypertrophy, those who achieved systolic BP < 130 ... Intensive BP lowering reduces CV events in patients with hypertension, LV hypertrophy Medscape: Nocturnal Nondipping and Left Ventricular Hypertrophy in Hypertension: An Updated Review Table 1. Prevalence of nondipping pattern in cross-sectional studies including more than 100 patients and assessing the relationship with left ventricular hypertrophy in essential hypertension.

Key Insights

Table ... Adolescents and young adults whose families have cardiometabolic disease are more likely than those without a family history to have left ventricular hypertrophy, with the prevalence growing fourfold ... The American Journal of Managed Care: More Black vs White Patients Have Risk Factors for LV Hypertrophy The parameter could potentially help clinicians zero in on the cause of left ventricular hypertrophy. Left atrial (LA) strain, as part of a complete echocardiographic workup, may help physicians ... BMJ: Association between race and maladaptive concentric left ventricular hypertrophy in American-style football athletes Objectives American-style football (ASF) athletes are at risk for the development of concentric left ventricular hypertrophy (C-LVH), an established cardiovascular risk factor in the general ...

Final Thoughts

Association between race and maladaptive concentric left ventricular hypertrophy in American-style football athletes